2019 Science2Startup Biotech Symposium - Call for Proposal

November 2, 2018

Science2Startup (S2S) is an invitation-only symposium for biotech entrepreneurship co-organized by Atlas Venture, F-Prime Capital, Osage University Partners, and RA Capital that will build connectivity across the academic, tech transfer, and venture capital communities.

This one-day symposium on April 23, 2019 in Cambridge, MA will feature presentations from top therapeutics researchers to a curated audience of experienced biotech venture capitalists, entrepreneurs at leading biotech startups, and senior executives at large pharma companies. Last year, 150 venture capitalists attended the event.

We invite you and the therapeutics-focused researchers at University of California - San Francisco to submit Non-confidential Proposals on our website, www.science2startup.com by November 2, 2018. Further details regarding submissions and the review process are provided on our website.

Over the coming months, Science2Startup senior advisors will select the most promising submissions to present at the event. Participating researchers will benefit from a mentorship program that will connect them with experienced investors and startup advisors who will help refine their company strategy and presentation prior to the event. Investigators from 40+ universities have presented their startup ideas at prior events, resulting in 13 companies receiving nearly $100 million in funding to date.

If you have any questions or concerns, please do not hesitate to contact us at: [email protected] or [email protected]

The S2S Steering Committee:

  • Uciane Scarlett, Atlas Venture
  • Lisa Huang, Atlas Venture
  • Alex Harding, Atlas Venture
  • Chong Xu, F-Prime Capital
  • Tiffany Yu, F-Prime Capital
  • Anurag Agarwal, Osage University Partners
  • Matthew Cohen, Osage University Partners
  • Chieze Ibeneche-Nnewihe, RA Capital
  • Daniel Marks, RA Capital
  • Danielle Feldman, RA Capital